The LENEA study is an international, prospective, open label, non-randomized multicenter
clinical research study designed to assess the safety and effectiveness of the NANO LV lead
Device: implantation of the new LV lead: NANO system.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01731210
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Approved indication per ACC/AHA/HRS guidelines for implantation of a CRT-D system for treatment of heart failure or life threatening ventricular tachyarrhythmia(s)
Receiving a new implant OR undergoing an upgrade from an existing ICD or pacemaker implant with no prior implanted LV lead OR undergoing a new LV implant attempt consecutive to a recent LV lead placement failure not related to coronary sinus cannulation failure
Patient receiving the PARADYM RF CRT or PARADYM RF CRT SONR devices
Ability to provide informed consent for study participation and is willing and able to comply with the prescribed follow-up tests and schedule of evaluations
Ventricular tachyarrhythmia of transient or reversible causes such as acute myocardial infarction, digitalis intoxication, drowning, electrocution, electrolyte imbalance, hypoxia or sepsis, uncorrected at the time of the enrolment;
Incessant Ventricular tachyarrhythmias;
Unstable angina, or acute MI , CABG , or PTCA within the past 4 weeks;
Correctable valvular disease that is the primary cause of heart failure;
Post heart transplant (patients who are waiting for a heart transplant are allowed in the study);
Patient who had previously a permanently implanted LV lead;
Concurrent implant with another pacemaker or ICD (previously implanted pacemaker or ICD devices should be removed prior to implant with the Paradym RF CRT-D or Paradym RF CRT SONR);
Already included in another clinical study that could confound the results of this study;
Life expectancy less than 1 year.
All locations for NCT01731210
CHU Charles Nicolle
Rouen, France, 76000
View full eligibility
Tris trial is registered with FDA with number: NCT01731210. The sponsor of the trial is LivaNova and it is looking for 9 volunteers for the current phase. Official trial title: Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!